Patient Leaflet Updated 26-Jun-2019 | Aspire Pharma Ltd
Solifenacin succinate 5mg/10mg film-coated tablets
Solifenacin succinate 5mg film-coated tablets
Solifenacin succinate 10mg film-coated tablets
Solifenacin succinate
1. What this medicine is and what it is used for
2. What you need to know before you take this medicine
3. How to take this medicine
4. Possible side effects
5. How to store this medicine
6. Contents of the pack and other information
The active substance solifenacin succinate belongs to the group of medicines called anticholinergics. These medicines are used to reduce the activity of an overactive bladder. This enables you to wait longer before having to go to the bathroom and increases the amount of urine that can be held by your bladder.
This medicine is used to treat the symptoms of a condition called overactive bladder. These symptoms include: having a strong, sudden urge to urinate without prior warning, having to urinate frequently or wetting yourself because you could not get to the bathroom in time.
Inform your doctor if you have or ever had any of the above mentioned conditions before treatment with solifenacin succinate starts.
Talk to your doctor or pharmacist before taking this medicine
Inform your doctor if you have or ever had any of the above conditions before treatment with solifenacin succinate starts.
Before you start taking this medicine, your doctor will assess whether there are other causes for your need to pass urine frequently (for example heart failure (insufficient pumping power of the heart) or kidney disease). If you have a urinary tract infection, your doctor will prescribe you an antibiotic (a treatment against particular bacterial infections).
This medicine is not to be used in children or adolescents under 18 years.
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.
It is especially important to inform your doctor if you are taking:
This medicine can be taken with or without food, depending on your preference.
You should not use this medicine if you are pregnant unless clearly necessary.
Do not use this medicine if you are breast-feeding as solifenacin succinate may get into your breast milk.
Ask your doctor or pharmacist for advice before taking this medicine.
This medicine may cause blurred vision and sometimes sleepiness or tiredness. If you suffer from any of these side effects, do not drive or operate machinery.
If you have been told by your doctor that you have a rare hereditary problem of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption you should not use this medicine.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
You should swallow the whole tablet with some liquid. It can be taken with or without food, according to your preference. Do not crush the tablets.
The recommended dose is 5mg per day, unless your doctor told you to take 10mg per day.
If you have taken too much of this medicine or if a child has accidentally taken solifenacin succinate, contact your doctor or pharmacist immediately.
Symptoms of overdose may include: headache, dry mouth, dizziness, drowsiness and blurred vision, perceiving things that are not there (hallucinations), over- excitability, seizures (convulsions), difficulty breathing, elevated heart rate (tachycardia), accumulation of urine in the bladder (urinary retention) and dilated pupils (mydriasis).
If you forget to take a dose at the usual time, take it as soon as you remember, unless it is time to take your next dose. Never take more than one dose per day. If you are in doubt, always consult your doctor or pharmacist.
If you stop taking this medicine, your symptoms of overactive bladder may return or worsen.
Always consult your doctor if you are considering stopping the treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience an allergic attack, or a severe skin reaction (e.g. blistering and peeling of the skin), you must inform your doctor or pharmacist immediately.
Angioedema (skin allergy that results in swelling that occurs in the tissue just below the surface of the skin) with airway obstruction (difficulty in breathing) has been reported in some patients on solifenacin succinate. If angioedema occurs, solifenacin succinate should be discontinued immediately and appropriate therapy and/or measures should be taken.
This medicine may cause the following other side effects:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
There are no special precautions for storage.
The active substance is solifenacin succinate.
The other ingredients are maize starch, lactose monohydrate, hypromellose, magnesium stearate, silica colloidal anhydrous, propyl gallate, polyethylene glycol, talc, titanium dioxide (E171) and iron oxide red (E172).
5mg tablets only: iron oxide yellow (E172).
Solifenacin succinate film-coated tablets are available in two strengths:
5mg tablets are pink coloured, round, biconvex, film-coated tablets marked with “5” on one side.
10mg tablets are red-brown coloured, round, biconvex, film-coated tablets marked with “10” on one side.
Available in pack sizes of 10, 20, 30, 50, 90, 100 film-coated tablets in blisters.
Not all pack sizes may be marketed.
Or
This leaflet was last revised in 08/2018.
1010466 - P1.6
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
+44 (0)1730 231148
http://www.aspirepharma.co.uk
+44 (0)1730 231148
+44 (0)1730 231148